Assessing the potential effects and cost-effectiveness of programmatic herpes zoster vaccination of elderly in the Netherlands

The potential cost-effectiveness of vaccination against herpes zoster and post-herpetic neuralgia

(2011) Marc Brisson et al.   Human vaccines & immunotherapeutics

Criteria for inclusion of vaccinations in public programmes

(2010) Hans Houweling et al.   VACCINE

Cost Effectiveness of Herpes Zoster Vaccine in Canada

(2009) Mehdi Najafzadeh et al.   PHARMACOECONOMICS

Increased Risk of Stroke After a Herpes Zoster Attack

(2009) Jiunn-Horng Kang et al.   STROKE

Estimating the cost-effectiveness of vaccination against herpes zoster in England and Wales

(2009) A.J. van Hoek et al.   VACCINE

Herpes Zoster–Related Hospitalizations and Expenditures Before and After Introduction of the Varicella Vaccine in the United States

(2008) Mitesh S. Patel et al.   INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Comparative Analyses of the 9 Glycoprotein Genes Found in Wild‐Type and Vaccine Strains of Varicella‐Zoster Virus

(2008) Johnathan Storlie et al.   JOURNAL OF INFECTIOUS DISEASES

The Epidemiological, Clinical, and Pathological Rationale for the Herpes Zoster Vaccine

(2008) Kenneth Schmader et al.   JOURNAL OF INFECTIOUS DISEASES

Development of Varicella Vaccine

(2008) Michiaki Takahashi et al.   JOURNAL OF INFECTIOUS DISEASES

Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: Uptake of the first new vaccine to target seniors

(2008) Peng-jun Lu et al.   VACCINE

Determinants of non-compliance with herpes zoster vaccination in the community-dwelling elderly

(2008) Wim Opstelten et al.   VACCINE

Distribution of varicella-zoster virus (VZV) wild-type genotypes in northern and southern Europe: Evidence for high conservation of circulating genotypes

(2008) Vladimir N. Loparev et al.   VIROLOGY